Хайлтын үр дүнгүүд - Roser Torrá
- 57-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
New therapeutic options for Alport syndrome -н Roser Torrá, Mónica Furlano
Хэвлэсэн 2019Revisão -
2
-
3
-
4
-
5
Diagnosis of autosomal dominant polycystic kidney disease using efficient <i>PKD1</i> and <i>PKD2</i> targeted next‐generation sequencing -н Daniel Trujillano, Gemma Bullich, Stephan Ossowski, José Ballarín, Roser Torrá, Xavier Estivill, Elisabet Ars
Хэвлэсэн 2014Artigo -
6
-
7
-
8
-
9
Coordinate Expression of the Autosomal Dominant Polycystic Kidney Disease Proteins, Polycystin-2 And Polycystin-1, in Normal and Cystic Tissue -н Albert Ong, Christopher J. Ward, Robin Butler, Simon Biddolph, Coleen Bowker, Roser Torrá, York Pei, Peter C. Harris
Хэвлэсэн 1999Artigo -
10
Prevalence of Cysts in Seminal Tract and Abnormal Semen Parameters in Patients with Autosomal Dominant Polycystic Kidney Disease -н Roser Torrá, Joaquim Sàrquella, Jordi Calabia, Jordi MartiCombining Acute Accent, Elisabet Ars, Patricia Fernández‐Llama, José Ballarín
Хэвлэсэн 2008Artigo -
11
Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression -н José Ballarín, Yolanda Arce, Roser Torra Balcells, Montserrat Díaz-Encarnación, F. Manzarbeitia, Alberto Ortíz, Jesús Egido, Juan Antonio Moreno
Хэвлэсэн 2011Artigo -
12
-
13
-
14
A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees -н Sandro Rossetti, Roser Torrá, Eliécer Coto, Mark Consugar, Vickie Kubly, S Málaga, Mercedes Navarro, Mounif El‐Youssef, Vicente E. Torres, Peter C. Harris
Хэвлэсэн 2003Artigo -
15
-
16
-
17
Corrigendum to “Long-term follow-up of renal function in patients treated with migalastat for Fabry disease” [Bichet et al., MGM Reports; 28 (2021) 100786] -н Daniel G. Bichet, Roser Torrá, Eric Wallace, Derralynn Hughes, Roberto Giugliani, Nina Skuban, Eva Krusinska, Ulla Feldt‐Rasmussen, Raphael Schiffmann, Kathy Nicholls
Хэвлэсэн 2021Errata/Corrigenda -
18
-
19
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations -н Johanna Temme, Frederik Peters, Katharina Lange, Yves Pirson, Laurence Heidet, Roser Torrá, Jean‐Pierre Grünfeld, Manfred Weber, Christoph Licht, G. A. Müller, Oliver Groß
Хэвлэсэн 2012Artigo -
20
Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity -н Gemma Bullich, Daniel Trujillano, Sheila Santín, Stephan Ossowski, Santiago Mendizábal, Gloria Fraga, A. Madrid, Gema Ariceta, José Ballarín, Roser Torrá, Xavier Estivill, Elisabet Ars
Хэвлэсэн 2014Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Disease
Kidney
Biology
Pathology
Kidney disease
Genetics
Intensive care medicine
Autosomal dominant polycystic kidney disease
Gene
Polycystic kidney disease
Glomerulonephritis
Alport syndrome
Renal function
Endocrinology
PKD1
Urology
Fabry disease
Gastroenterology
Mutation
Autosomal Recessive Polycystic Kidney Disease
Compound heterozygosity
Computer science
Family medicine
Focal segmental glomerulosclerosis
Genetic testing
Law
Nephrotic syndrome
Phenotype